Systemic methotrexate in the management of ectopic pregnancy and pregnancy of unknown location

Ectopic pregnancy (EP) occurs in 2% of all spontaneous conceptions. It can be a life-threatening condition and is the most common cause of mortality during the first trimester of pregnancy, contributing to 7% of all pregnancy-related deaths.1,2 The risk factors for EP include tubal damage following...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of the Academy of Medicine, Singapore Singapore, 2023-07, Vol.52 (7), p.378-379
Hauptverfasser:	Soe, Ni Ni, Kathirvel, Rajeswari, Ong, Kai Zhi, Saravanaa, Raajalakshmi Madurai, Chonkar, Sonali Prashant, Mathur, Manisha
Format:	Artikel
Sprache:	eng
Schlagworte:	Abortifacient Agents, Nonsteroidal - administration & dosage Abortifacient Agents, Nonsteroidal - therapeutic use Adult Female Humans Methotrexate - administration & dosage Methotrexate - therapeutic use Pregnancy Pregnancy, Ectopic - diagnosis Pregnancy, Ectopic - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!